{
    "clinical_study": {
        "@rank": "114205", 
        "acronym": "APPOSE", 
        "arm_group": [
            {
                "arm_group_label": "Cobalt Chromium Everolimus-eluting stent (Xience Prime)", 
                "arm_group_type": "Active Comparator", 
                "description": "Cobalt Chromium Everolimus-eluting stent (Xience Prime)"
            }, 
            {
                "arm_group_label": "Platinum Chromium Everolimus-eluting stent (Promus Element)", 
                "arm_group_type": "Active Comparator", 
                "description": "Platinum Chromium Everolimus-eluting stent (Promus Element)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the trial is to directly compare the Cobalt Chromium platform\n      everolimus-eluting stent, Xience Prime\u2122, with the Platinum Chromium platform\n      everolimus-eluting stent, Promus Element\u2122, in relation to stent scaffolding shape, position\n      with the heart blood vessel and extent of tissue coverage (at 6 months) using optical\n      coherence tomography.\n\n      Hypotheses:\n\n        1. The alloy composition and strut design of a drug-eluting stent has a direct bearing on\n           stent apposition measured using OCT.\n\n        2. Stent design and alloy composition have a direct influence on radial support and\n           scaffold shrinkage."
        }, 
        "brief_title": "Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age \u2265 18 years\n\n          2. Symptomatic coronary artery disease including patients with chronic stable angina,\n             silent ischemia, and acute coronary syndromes including non-ST elevation myocardial\n             infarction\n\n          3. Presence of one or more coronary artery stenosis > 50% in a native coronary artery\n             with a reference diameter ranging from 2.25 to 4.25 mm which can be covered with one\n             or multiple stents\n\n          4. No limitation to the number of treated lesions or number of vessels according to the\n             randomization group\n\n          5. De-novo native coronary disease with complex lesions involving: Bifurcations, chronic\n             occlusions > 3 months, lesions > 20mm in length or moderately/heavily calcified\n             lesions of any length\n\n        Exclusion Criteria:\n\n          1. Known intolerance to aspirin, clopidogrel, heparin, cobalt chromium, platinum\n             chromium, everolimus, contrast material\n\n          2. Acute ST-segment elevation myocardial infarction\n\n          3. Type A lesion including vessel angulation <45 degrees\n\n          4. Bypass graft\n\n          5. Inability to provide informed consent\n\n          6. Pregnancy\n\n          7. Planned surgery within 12 months of PCI unless dual antiplatelet therapy is\n             maintained throughout the peri-surgical period\n\n          8. Left ventricular ejection fraction < 25%\n\n          9. Serum creatinine > 180mmol/L"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01776567", 
            "org_study_id": "01/12"
        }, 
        "intervention": {
            "arm_group_label": [
                "Cobalt Chromium Everolimus-eluting stent (Xience Prime)", 
                "Platinum Chromium Everolimus-eluting stent (Promus Element)"
            ], 
            "intervention_name": "Everolimus eluting stents", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Chromium", 
                "Cobalt", 
                "Everolimus", 
                "Sirolimus"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "coronary artery disease", 
            "stents", 
            "optical imaging"
        ], 
        "lastchanged_date": "January 23, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Harry Lowe"
                }, 
                "facility": {
                    "address": {
                        "city": "Concord", 
                        "country": "Australia", 
                        "state": "New South Wales"
                    }, 
                    "name": "Concord Repatriation Hospital"
                }, 
                "investigator": {
                    "last_name": "Harry Lowe", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Darren Walters"
                }, 
                "facility": {
                    "address": {
                        "city": "Brisbane", 
                        "country": "Australia", 
                        "state": "Queensland"
                    }, 
                    "name": "The Prince Charles Hospital"
                }, 
                "investigator": {
                    "last_name": "Darren Walters", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "rita.wong@nh.org.au", 
                    "last_name": "Rita Wong"
                }, 
                "facility": {
                    "address": {
                        "city": "Epping", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3076"
                    }, 
                    "name": "Northern Hospital"
                }, 
                "investigator": {
                    "last_name": "Peter Barlis, MBBS PHD FRACP", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Robert Whitbourn"
                }, 
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3065"
                    }, 
                    "name": "St Vincent's Hospital"
                }, 
                "investigator": {
                    "last_name": "Robert Whitbourn", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms.", 
        "overall_contact": {
            "email": "pbarlis@unimelb.edu.au", 
            "last_name": "Peter Barlis, MBBS MPH PHD FESC FRACP", 
            "phone": "+61 3 8405 8554"
        }, 
        "overall_official": {
            "affiliation": "Northern Hospital", 
            "last_name": "Peter Barlis", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Australia: Human Research Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "\u2022 Percent incomplete stent apposition using OCT of the CoCr-EES versus the PtCr-EES stent inflated to nominal pressure and following optimal post-dilatation. Stent length (mm) at implantation following nominal pressure and following post-dilatation", 
            "safety_issue": "No", 
            "time_frame": "Immediately following stent deployment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01776567"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Northern Hospital, Australia", 
            "investigator_full_name": "Dr Peter Barlis", 
            "investigator_title": "Interventional Cardiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Percentage of uncovered stent struts", 
                "safety_issue": "No", 
                "time_frame": "6 mths post initial PCI procedure"
            }, 
            {
                "measure": "Mean neointimal tissue thickness (microns)", 
                "safety_issue": "No", 
                "time_frame": "6 months post initial PCI Procedure"
            }, 
            {
                "measure": "Stent length (mm) measured using OCT", 
                "safety_issue": "No", 
                "time_frame": "6 months post initial PCI procedure"
            }
        ], 
        "source": "Northern Hospital, Australia", 
        "sponsors": {
            "collaborator": {
                "agency": "Abbott Vascular", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Northern Hospital, Australia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}